2010
DOI: 10.1158/1078-0432.ccr-10-0185
|View full text |Cite
|
Sign up to set email alerts
|

Targeting Cell Division Cycle 7 Kinase: A New Approach for Cancer Therapy

Abstract: The cell division cycle 7 (Cdc7) is a serine-threonine kinase, originally discovered in budding yeast, required to initiate DNA replication. Human Cdc7 phosphorylates the minichromosome maintenance protein 2 (Mcm2), a component of the DNA replicative helicase needed for genome duplication. Inhibition of Cdc7 in cancer cells impairs progression through S phase, inducing a p53-independent apoptotic cell death, whereas in normal cells, it does not affect cell viability. Small molecule compounds able to interfere … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
104
0
1

Year Published

2011
2011
2023
2023

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 104 publications
(108 citation statements)
references
References 51 publications
3
104
0
1
Order By: Relevance
“…5 or 10 M of PHA767491 completely blocked the cell growth (Fig. 2E), consistent with its function in the initiation of DNA replication (25)(26)(27)32). These data suggest that Cdc7 mediates both the cell proliferation and SMC differentiation induced by TGF-␤.…”
Section: Cdc7 Expression Is Increased In Tgf-␤-induced Proliferationsupporting
confidence: 74%
“…5 or 10 M of PHA767491 completely blocked the cell growth (Fig. 2E), consistent with its function in the initiation of DNA replication (25)(26)(27)32). These data suggest that Cdc7 mediates both the cell proliferation and SMC differentiation induced by TGF-␤.…”
Section: Cdc7 Expression Is Increased In Tgf-␤-induced Proliferationsupporting
confidence: 74%
“…Several biopharma companies have initiated Cdc7 drug development programmes, some of which have reached early-stage clinical trials [130,131]. First-in-class Cdc7 inhibitors have broad tumour spectrum activity in preclinical models, consistent with loss of the protective checkpoint mechanism in most tumour types.…”
Section: The Dna Replication Initiation Machinery-a Promising Anti-camentioning
confidence: 99%
“…Inhibition of Cdc7 kinase activity results in a decrease of Mcm2 phosphorylation, restricts DNA replication, and induces apoptotic cell death (60,234). Several Cdc7 inhibtors have been analyzed in preclinical studies, and two of these inhibitors are currently in phase I clinical development (233,318).…”
Section: Inhibiting Celt Cycte Entry or Progressionmentioning
confidence: 99%